The Valley Desk

NCT03345082 · Interventional trial

A Dose Ranging Study of OPT-302 With Ranibizumab in Neovascular (Wet) AMD

Overall registry status Completed

Phase 2

Conditions Neovascular Age-related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov